Search Results

Arformoterol.

• Authors : Abdelghany, Osama; Man-Yee Men

Subjects: BRONCHODILATOR agents; OBSTRUCTIVE lung diseases; LUNG diseasesUNITED States

• Source: Formulary. Feb2007, Vol. 42 Issue 2, p99-109. 7p.

Record details

Patients with severe COPD may benefit from the addition of an inhaled corticosteroid.

Subjects: OBSTRUCTIVE lung diseases; BRONCHODILATOR agents; CORTICOSTEROIDS

• Source: Formulary. Mar2007, Vol. 42 Issue 3, p178-183. 2p.

Record details

Increased cardiac risks in COPD with new Rx inhalers.

Subjects: BRONCHODILATOR agents; HEART diseases; OBSTRUCTIVE lung diseases

• Source: Formulary. Jun2013, Vol. 48 Issue 6, p185-185. 3/5p.

Record details

Ipratropium lowers overall COPD treatment costs compared with albuterol.

Subjects: BRONCHODILATOR agents; OBSTRUCTIVE lung diseases; ALBUTEROL

• Source: Formulary. Jun99, Vol. 34 Issue 6, p492. 1/2p.

Record details

Management of chronic obstructive pulmonary disease: An emphasis on recently approved medications and products in the pipeline.

• Authors : Hudd, Timothy R. (AUTHOR); Zaiken, Kathy (AUTHOR)

Subjects: ADRENOCORTICAL hormones; HORMONE therapy; HYDROCARBONS

• Source: Formulary. Sep2011, Vol. 46 Issue 9, p374-393. 12p. 1 Color Photograph, 5 Charts.

Record details

Two major new guidelines issued for management of COPD.

• Source: Formulary. 2001, Vol. 36, Issue 6, pages. 423

Record details

Indacaterol.

• Source: Formulary. 2007, Vol. 42, Issue 7, pages. 1

Record details

QAB149 (Novartis) once-daily bronchodilator for the treatment of adult patients.

• Source: Formulary. 2009, Vol. 44, Issue 12, pages. 1

Record details

First-time generic approvals.

• Source: Formulary. 2007, Vol. 42, Issue 3, pages. 1

Record details

Inhaled liposomal formulation of ciprofloxacin (Aradigm).

• Source: Formulary. 2007, Vol. 42, Issue 3, pages. 1

Record details